AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2010

Jun 1, 2010

30291_dirs_2010-06-01_e0e55de2-b6ea-46c1-aabb-7fcdf489c6fa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2010-05-28

Reporting Person: DORSA CAROLINE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-05-28	Common Stock	P	208	$48.0086	Acquired	1555	Direct

Footnotes

F1: Purchase pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2: Full information regarding the number of shares purchased at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.

F3: This represents the weighted average price for shares purchased at a range between $47.59 (low) and $48.12 (high).